| 1 |
Arepally GM. Heparin-induced thrombocytopenia[J]. Blood, 2017, 129(21): 2864-2872.
|
| 2 |
Joseph J, Rabbolini D, Enjeti AK, et al. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group[J]. Med J Aust, 2019, 210(11): 509-516.
|
| 3 |
Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia[J]. Blood Adv, 2018, 2(22): 3360-3392.
|
| 4 |
中国医师协会心血管内科医师分会血栓防治专业委员会《中华医学杂志》编辑委员会. 肝素诱导的血小板减少症中国专家共识(2017）[J]. 中华医学杂志, 2018, 98(6): 408-417.
|
| 5 |
Cavarocchi NC. Introduction to Extracorporeal Membrane Oxygenation[J]. Crit Care Clin, 2017, 33(4): 763-766.
|
| 6 |
Hill JD, O′Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung[J]. N Engl J Med, 1972, 286(12): 629-634.
|
| 7 |
Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome[J]. JAMA, 2009, 302(17): 1888-1895.
|
| 8 |
Pham T, Combes A, Rozé H, et al. Extracorporealmembrane oxygenation for pandemic influenza A (H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis[J]. Am J Respir Crit Care Med, 2013, 187: 276-85.
|
| 9 |
Cavarocchi NC. Introduction to Extracorporeal Membrane Oxygenation[J]. Crit Care Clin, 2017, 33(4): 763-766.
|
| 10 |
黑飞龙，龙村. 体外膜肺氧合并发症防治进展[J]. 中国体外循环杂志, 2007, 5(4): 250-252.
|
| 11 |
Pollak U. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants[J]. J Thromb Haemost, 2019, 17(10): 1608-1622.
|
| 12 |
Pollak U. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants[J]. Perfusion, 2018, 33(1_suppl): 7-17.
|
| 13 |
Cuker A, Arepally G, Crowther MA, et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion[J]. J Thromb Haemost, 2010, 8(12): 2642-2650.
|
| 14 |
Younis M, Ya′qoub L, Ali Z, et al. Comparison of a clinical-laboratory algorithm, 4t and heparin-induced thrombocytopenia expert probability scores in the diagnosis of heparin-induced thrombocytopenia in the critical care setting[J]. Am J Blood Res, 2019, 9(3): 25-33.
|
| 15 |
Li S, Fan LK, Wang SJ, et al. Prospective evaluation of heparin-induced thrombocytopenia expert probability and 4T scores in Chinese patients with suspected heparin-induced thrombocytopenia[J]. Chin Med J (Engl), 2019, 132(12): 1441-1447.
|
| 16 |
Vayne C, Guery EA, Kizlik-Masson C, et al. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin- induced thrombocytopenia antibodies[J]. Br J Haematol, 2017, 179(5): 811-819.
|
| 17 |
Pandya KA, Johnson EG, Davis GA, et al. Serotonin release assay (SRA)-negative HIT: a newly recognized entity: implications for diagnosis and management[J]. Thromb Res, 2018, 172: 169-171
|
| 18 |
Warkentin TE, Nazy I, Sheppard JI, et al. Serotonin-release assay-negative heparin-induced thrombocytopenia[J]. Am J Hematol, 2020, 95(1): 38-47.
|
| 19 |
Fathi M. Heparin-induced thrombocytopenia (HIT): Identification and treatment Pathways[J]. Glob Cardiol Sci Pract, 2018, 2018(2): 15.
|
| 20 |
宋景春，刘树元，朱峰, 等. 中国成人重症患者血小板减少诊疗专家共识[J]. 解放军医学杂志, 2020, 45(2): 95-112.
|
| 21 |
Rougé A, Pelen F, Durand M, et al. Argatroban for an alternative anticoagulant in HIT during ECMO[J]. J Intensive Care, 2017, 5: 39.
|
| 22 |
Sin JH, Lopez ND. Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration[J]. J Extra Corpor Technol, 2017, 49(2): 115-120.
|
| 23 |
Phillips MR, Khoury AI, Ashton RF, et al. The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution[J]. Anaesth Intensive Care, 2014, 42(1): 97-98.
|
| 24 |
Koster A, Niedermeyer J, Gummert J, et al. Low dose bivalirudin anticoagulation for lung transplantation with extracorporeal membrane oxygenation in a patient with acute heparin-induced thrombocytopenia[J]. Eur J Cardiothorac Surg, 2017, 51(5): 1009-1011.
|
| 25 |
Netley J, Roy J, Greenlee J, et al. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review[J]. J Extra Corpor Technol, 2018, 50(3): 161-166.
|
| 26 |
Pieri M, Agracheva N, Bonaveglio E, et al. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study[J]. J Cardiothorac Vasc Anesth, 2013, 27(1): 30-34.
|
| 27 |
Berei TJ, Lillyblad MP, Wilson KJ, et al. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation[J]. ASAIO J, 2018, 64(5): 623-629.
|
| 28 |
Macielak S, Burcham P, Whitson B, et al. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy[J]. Perfusion, 2019, 34(8): 671-678.
|
| 29 |
Netley J, Roy J, Greenlee J, et al. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review[J]. J Extra Corpor Technol, 2018, 50(3): 161-166.
|
| 30 |
Parlar AI, Sayar U, Cevirme D, et al. Successful use of fondaparinux in a patient with heparin-induced thrombocytopenia while on extracorporeal membrane oxygenation after mitral valve redo surgery[J]. Int J Artif Organs, 2014, 37(4): 344-347.
|
| 31 |
Bauer C, Vichova Z, Ffrench P, et al. Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism[J]. Anesth Analg, 2008, 106(4): 1101-1103,
|
| 32 |
Dager WE, Gosselin RC, Yoshikawa R, et al. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation[J]. Ann Pharmacother, 2004, 38(4): 598-601.
|
| 33 |
Balasubramanian SK, Tiruvoipati R, Chatterjee S, et al. Extracorporeal membrane oxygenation with lepirudin anticoagulation for Wegener′s granulomatosis with heparin-induced thrombocytopenia[J]. ASAIO J, 2005, 51(4): 477-479.
|